ID: ALA4558269

Max Phase: Preclinical

Molecular Formula: C31H35F4N7O8S

Molecular Weight: 627.70

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cccc(F)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCN(S(=O)(=O)c2cccc(NC(=O)/C=C/CN(C)C)c2)CC1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C29H34FN7O6S.C2HF3O2/c1-36(2)14-6-11-25(38)32-20-7-4-8-21(17-20)44(41,42)37-15-12-19(13-16-37)33-29(40)27-23(18-31-35-27)34-28(39)26-22(30)9-5-10-24(26)43-3;3-2(4,5)1(6)7/h4-11,17-19H,12-16H2,1-3H3,(H,31,35)(H,32,38)(H,33,40)(H,34,39);(H,6,7)/b11-6+;

Standard InChI Key:  CLKAQFHAOUAOJN-ICSBZGNSSA-N

Associated Targets(Human)

CDK14 Tchem Cyclin-dependent kinase 14/Cyclin-Y (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 627.70Molecular Weight (Monoisotopic): 627.2275AlogP: 2.45#Rotatable Bonds: 11
Polar Surface Area: 165.83Molecular Species: BASEHBA: 8HBD: 4
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.74CX Basic pKa: 8.80CX LogP: 2.04CX LogD: 0.72
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.24Np Likeness Score: -1.74

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source